Implications of the COVID-19 Pandemic on Medical Loss Ratio for Health Plans

HealthExecStore

Please join us as Milliman’s Jennifer Carioto, Andrew Bochner, and Luis O. Maldonado Irizarry, discuss the initial and longer-range impact of COVID-19 on health plan MLR including market-specific considerations for Commercial, MA and Medicaid, in the HealthcareWebSummit event: Implications of the COVID-19 Pandemic on Medical Loss Ratio for Health Plans.

• Review of Medical Loss Ratio formula, requirements and current issues
• COVID-19 initial MLR impact 
• Market-specific considerations for Commercial, Medicare Advantage and Medicaid
• COVID-19 future implications and considerations

Faculty: Jennifer Carioto, FSA, MAAA, Principal and Consulting Actuary, Milliman; Andrew Bochner, FSA, MAAA, Consulting Actuary, Milliman; and Luis O. Maldonado Irizarry, FSA, MAAA, Principal and Consulting Actuary, Milliman

The COVID-19 pandemic will have a significant impact in all segments of healthcare for a prolonged period. As such, health plans have critical financial decisions to make in the upcoming months with limited data available and wide uncertainty on how the COVID-19 pandemic will transition toward the end of 2020 and into 2021. 

This session explores how COVID-19 may impact a health plan’s medical loss ratio (MLR) requirements in general and provides specific considerations for the Commercial, Medicare Advantage and Medicaid markets at the end of 2020 and into the future.

More Information, How to Register